Trials / Recruiting
RecruitingNCT07456865
Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 256 (estimated)
- Sponsor
- MedtronicNeuro · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this prospective, multicenter study is to assess the long-term safety and effectiveness of the Altaviva™ system for the treatment of UUI
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Altaviva™ system | Programmable neurostimulation system that delivers electrical stimulation to the tibial nerve for tibial neuromodulation therapy. |
Timeline
- Start date
- 2026-03-17
- Primary completion
- 2032-11-01
- Completion
- 2032-11-01
- First posted
- 2026-03-09
- Last updated
- 2026-03-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07456865. Inclusion in this directory is not an endorsement.